Clinical Trial Update: D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults [Phase 2]

View source ↗

Summary

Phase 2 study in ART-naive HIV-1 infected adults comparing D/C/F/TAF to cobicistat-boosted darunavir plus FTC/TDF. The trial completed and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Cobicistat (cobicistat)
• Darunavir (darunavir)
• Emtricitabine (Emtricitabine)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Gilead Sciences | Conditions: Acquired Immunodeficiency Syndrome, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2016-04-11